Mutual Fund Details

ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct-IDCW

Equity Pharma

NAV

₹15.0000

as on 06 Feb 2023, 11:20 PM

₹0.0400(0.27%)

Last Change

Schemes Managed By

Dharmesh Kakkad

Fund Manager

Investment Performance

would have given a return of

₹1,10,871

₹1,21,647

₹1,71,060

₹1,76,237

Bank Account

Fixed Deposit

Regular Mutual Fund

This Fund on Paytm Money

This Mutual Fund

₹76,238

Profit (absolute return)

76.24%

in the last

max

+1% Higher Returns

With Direct Plans on Paytm Money

Investment Returns

In the last 3 months

6.67%

In the last 6 months

3.36%

In the last 1 year

6.19%

In the last 3 years

76.24%

In the last 5 years

In the last 10 years

Absolute Returns

CAGR

Scheme Riskometer

low

low to moderate

moderate

moderately high

high

very high

Investors understand that their principal will be at very high risk

Scheme Information

ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct-IDCW

as of 31 Dec 2022, 05:30 AM

₹2,513.92 Cr

Scheme Asset Size

Fund Type

Open-End

Exit Load

Exit load of 1% if redeemed within 15 days.

1.21%

Expense Ratio

Plan

Dividend

2.68%

Cash Holding

Benchmark

S&P BSE Healthcare Total Return Index

Scheme Document

View

Benchmark

S&P BSE Healthcare Total Return Index

Exit Load

Exit load of 1% if redeemed within 15 days.

Scheme Document

View

Sectors Holding in this Mutual Fund

as on 31 Dec 2022

Sort By

Value

Sector

Healthcare

92.84%

₹2,333.95 Cr

Insurance

4.31%

₹108.45 Cr

Cash Holding

2.68%

₹67.43 Cr

Others

0.16%

₹4.02 Cr

Sectors Holding in this Mutual Fund

as on 31 Dec 2022

Sort By

Value

Sector

Healthcare

92.84%

₹2,333.95 Cr

Insurance

4.31%

₹108.45 Cr

Cash Holding

2.68%

₹67.43 Cr

Others

0.16%

₹4.02 Cr

Companies Holding in this Mutual Fund

as on 31 Dec 2022

Sort By

Value

Company

Sun Pharmaceutical Inds. Ltd.

16.94%

₹425.86 Cr

Dr. Reddy's Laboratories Ltd.

8.26%

₹207.65 Cr

Lupin Ltd. - (Preference Shares)

5.09%

₹127.96 Cr

Apollo Hospitals Enterprise Ltd.

4.91%

₹123.43 Cr

Alkem Laboratories Ltd.

4.81%

₹120.92 Cr

Others

59.99%

₹1,508.10 Cr

View All

Companies Holding in this Mutual Fund

as on 31 Dec 2022

Sort By

Value

Company

Sun Pharmaceutical Inds. Ltd.

16.94%

₹425.86 Cr

Dr. Reddy's Laboratories Ltd.

8.26%

₹207.65 Cr

Lupin Ltd. - (Preference Shares)

5.09%

₹127.96 Cr

Apollo Hospitals Enterprise Ltd.

4.91%

₹123.43 Cr

Alkem Laboratories Ltd.

4.81%

₹120.92 Cr

Others

59.99%

₹1,508.10 Cr

View All

Funds in this Category

This fund's returns:

20.77%

Return Duration

3 Years

DSP Healthcare Fund Direct - Growth

Mirae Asset Healthcare Fund Direct - Growth

ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth

About ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct-IDCW

ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct-IDCW is a Equity mutual fund scheme from ICICI Prudential Mutual Fund. This scheme was launched on Invalid date and is currently managed by its fund manager Dharmesh Kakkad. It has an AUM of ₹2,513.92 Crores and the latest NAV decalared is ₹15.000 as on 07 Feb 2023 at 10:15 am.

ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct-IDCW scheme return performance in last 1 year is -6.19%, in last 3 years is 76.24% and 97.65% since scheme launch. The min. SIP amount to invest in this scheme is ₹100.